← Leaderboards
Marion Avril
Malarvx, Inc.
$223,725
Attributed
$447,450
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $230.3K · FY2020–21$250K$187.5K$125K$62.5K$0
'20
'21
Funding mix
By agency
NIH$447,450 · 1
By mechanism
R43$447,450 · 1
Top collaborators
- Brandon Keith Wilder2 shared
Others in their field
Other Emerging Leaders on “Antigens”
- Timothy Fouts · Advanced Bioscience Laboratories, Inc.$42,191,190
- Bala Raja · Luminostics, Inc.$28,624,460
- Hanjoon Ryu$28,519,898
- Thomas Denny · Duke University$22,999,550
- Jay Evans · University Of Montana$22,565,626
- Julie Ake · National Institute Of Allergy And Infectious Diseases$22,000,000
Research focus
AntigensAntimalarialsAotus PrimateAttenuatedAttenuated VaccinesAttenuationBaseBedsBenchmarkingBiologicalBloodCell Culture TechniquesCell MotilityCellsCessation Of LifeCharacteristicsChemoprophylaxisCircumsporozoite ProteinClinical DevelopmentClinical TrialsCollaborationsCommercializationCost EffectiveAnimals